Post-translational modifications in mitochondria: protein signaling in the powerhouse

Cellular and Molecular Life Sciences

Volumn 73, Issue 21, 2016, Pages 4063-4073

  Stram, Amanda R ^a   Payne, R Mark ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acetylation; Metabolism; Mitochondria; Post translational modification

Indexed keywords

ADENOSINE DIPHOSPHATE; NITROGEN DERIVATIVE; REACTIVE OXYGEN METABOLITE; LYSINE; MITOCHONDRIAL PROTEIN;

ACETYLATION; ACYLATION; APOPTOSIS; AUTOPHAGY; CARDIOVASCULAR DISEASE; CELL FUNCTION; CELL METABOLISM; DEACETYLATION; DIABETES MELLITUS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HUMAN; METABOLIC SYNDROME X; MITOCHONDRION; NERVE DEGENERATION; NUTRIENT AVAILABILITY; PATHOPHYSIOLOGY; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; PROTEOMICS; REDOX STRESS; REVIEW; SCREENING TEST; ANIMAL; METABOLISM; OXIDATION REDUCTION REACTION; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; LYSINE; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; OXIDATION-REDUCTION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION;

EID: 84971013948     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-016-2280-4     Document Type: Review

References (147)

1. DeBerardinis RJ, Thompson CB (2012) Cellular metabolism and disease: what do metabolic outliers teach us? Cell 148(6):1132–1144
2. Nunnari J, Suomalainen A (2012) Mitochondria: in sickness and in health. Cell 148(6):1145–1159
3. Salminen A et al (2012) Mitochondrial dysfunction and oxidative stress activate inflammasomes: impact on the aging process and age-related diseases. Cell Mol Life Sci 69(18):2999–3013
4. Walters AM, Porter GA Jr, Brookes PS (2012) Mitochondria as a drug target in ischemic heart disease and cardiomyopathy. Circ Res 111(9):1222–1236
5. Zsurka G, Kunz WS (2013) Mitochondrial involvement in neurodegenerative diseases. IUBMB Life 65(3):263–272
6. Cardaci S, Ciriolo MR (2012) TCA cycle defects and cancer: when metabolism tunes redox state. Int J Cell Biol 2012:161837
7. Desideri E, Vegliante R, Ciriolo MR (2015) Mitochondrial dysfunctions in cancer: genetic defects and oncogenic signaling impinging on TCA cycle activity. Cancer Lett 356(2 Pt A):217–223
8. Lesnefsky EJ et al (2001) Mitochondrial dysfunction in cardiac disease: ischemia–reperfusion, aging, and heart failure. J Mol Cell Cardiol 33(6):1065–1089
9. Huss JM, Kelly DP (2005) Mitochondrial energy metabolism in heart failure: a question of balance. J Clin Invest 115(3):547–555
10. Bugger H et al (2010) Proteomic remodelling of mitochondrial oxidative pathways in pressure overload-induced heart failure. Cardiovasc Res 85(2):376–384
11. Boudina S et al (2005) Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation 112(17):2686–2695
12. Koc EC, Koc H (2012) Regulation of mammalian mitochondrial translation by post-translational modifications. Biochim Biophys Acta 1819(9–10):1055–1066
13. Papanicolaou KN, O’Rourke B, Brian Foster D (2014) Metabolism leaves its mark on the powerhouse: recent progress in post-translational modifications of lysine in mitochondria. Front Physiol 5:301
14. Zhao S et al (2010) Regulation of cellular metabolism by protein lysine acetylation. Science 327(5968):1000–1004
15. Menzies KJ et al (2016) Protein acetylation in metabolism-metabolites and cofactors. Nat Rev Endocrinol 12:43–60
16. Song BJ et al (2014) Mitochondrial dysfunction and tissue injury by alcohol, high fat, nonalcoholic substances and pathological conditions through post-translational protein modifications. Redox Biol 3:109–123
17. Hofer A, Wenz T (2014) Post-translational modification of mitochondria as a novel mode of regulation. Exp Gerontol 56:202–220
18. Gould N et al (2013) Regulation of protein function and signaling by reversible cysteine S-nitrosylation. J Biol Chem 288(37):26473–26479
19. Teague WM et al (1979) Function of phosphorylation sites on pyruvate dehydrogenase. Biochem Biophys Res Commun 87(1):244–252
20. Tibaldi E et al (2008) Src-Tyrosine kinases are major agents in mitochondrial tyrosine phosphorylation. J Cell Biochem 104(3):840–849
21. Hebert-Chatelain E (2013) Src kinases are important regulators of mitochondrial functions. Int J Biochem Cell Biol 45(1):90–98
22. Hebert-Chatelain E et al (2012) Preservation of NADH ubiquinone-oxidoreductase activity by Src kinase-mediated phosphorylation of NDUFB10. Biochim Biophys Acta 1817(5):718–725
23. Papa S et al (1996) The nuclear-encoded 18 kDa (IP) AQDQ subunit of bovine heart complex I is phosphorylated by the mitochondrial cAMP-dependent protein kinase. FEBS Lett 379(3):299–301
24. Papa S et al (2001) Mutation in the NDUFS4 gene of complex I abolishes cAMP-dependent activation of the complex in a child with fatal neurological syndrome. FEBS Lett 489(2–3):259–262
25. He L, Lemasters JJ (2005) Dephosphorylation of the Rieske iron-sulfur protein after induction of the mitochondrial permeability transition. Biochem Biophys Res Commun 334(3):829–837
26. Augereau O et al (2005) Identification of tyrosine-phosphorylated proteins of the mitochondrial oxidative phosphorylation machinery. Cell Mol Life Sci 62(13):1478–1488
27. Acin-Perez R et al (2011) Protein phosphorylation and prevention of cytochrome oxidase inhibition by ATP: coupled mechanisms of energy metabolism regulation. Cell Metab 13(6):712–719
28. Acin-Perez R et al (2011) A phosphodiesterase 2A isoform localized to mitochondria regulates respiration. J Biol Chem 286(35):30423–30432
29. Miyazaki T et al (2003) Regulation of cytochrome c oxidase activity by c-Src in osteoclasts. J Cell Biol 160(5):709–718
30. Boerner JL et al (2004) Phosphorylation of Y845 on the epidermal growth factor receptor mediates binding to the mitochondrial protein cytochrome c oxidase subunit II. Mol Cell Biol 24(16):7059–7071
31. Ding Y et al (2012) Receptor tyrosine kinase ErbB2 translocates into mitochondria and regulates cellular metabolism. Nat Commun 3:1271
32. Lewandrowski U et al (2008) Identification of new tyrosine phosphorylated proteins in rat brain mitochondria. FEBS Lett 582(7):1104–1110
33. Yuan S et al (2008) Voltage-dependent anion channel 1 is involved in endostatin-induced endothelial cell apoptosis. FASEB J 22(8):2809–2820
34. Wegrzyn J et al (2009) Function of mitochondrial Stat3 in cellular respiration. Science 323(5915):793–797
35. Heusch G et al (2011) Mitochondrial STAT3 activation and cardioprotection by ischemic postconditioning in pigs with regional myocardial ischemia/reperfusion. Circ Res 109(11):1302–1308
36. Boengler K et al (2008) The myocardial JAK/STAT pathway: from protection to failure. Pharmacol Ther 120(2):172–185
37. Paulsen CE, Carroll KS (2013) Cysteine-mediated redox signaling: chemistry, biology, and tools for discovery. Chem Rev 113(7):4633–4679
38. Kramer PA et al (2015) The measurement of reversible redox dependent post-translational modifications and their regulation of mitochondrial and skeletal muscle function. Front Physiol 6:347
39. Mailloux RJ, Jin X, Willmore WG (2014) Redox regulation of mitochondrial function with emphasis on cysteine oxidation reactions. Redox Biol 2:123–139
40. Levonen AL et al (2014) Redox regulation of antioxidants, autophagy, and the response to stress: implications for electrophile therapeutics. Free Radic Biol Med 71:196–207
41. Victorino VJ, Mencalha AL, Panis C (2015) Post-translational modifications disclose a dual role for redox stress in cardiovascular pathophysiology. Life Sci 129:42–47
42. 2, a necessary evil for cell signaling. Science 312(5782):1882–1883
43. Kornfeld OS et al (2015) Mitochondrial reactive oxygen species at the heart of the matter: new therapeutic approaches for cardiovascular diseases. Circ Res 116(11):1783–1799
44. Chen YR, Zweier JL (2014) Cardiac mitochondria and reactive oxygen species generation. Circ Res 114(3):524–537
45. Saitoh S et al (2006) Hydrogen peroxide: a feed-forward dilator that couples myocardial metabolism to coronary blood flow. Arterioscler Thromb Vasc Biol 26(12):2614–2621
46. Chang AH et al (2014) Respiratory substrates regulate S-nitrosylation of mitochondrial proteins through a thiol-dependent pathway. Chem Res Toxicol 27(5):794–804
47. Chouchani ET et al (2010) Identification of S-nitrosated mitochondrial proteins by S-nitrosothiol difference in gel electrophoresis (SNO-DIGE): implications for the regulation of mitochondrial function by reversible S-nitrosation. Biochem J 430(1):49–59
48. Martinez-Ruiz A, Lamas S (2004) S-nitrosylation: a potential new paradigm in signal transduction. Cardiovasc Res 62(1):43–52
49. Murphy E et al (2014) Signaling by S-nitrosylation in the heart. J Mol Cell Cardiol 73:18–25
50. Piantadosi CA (2012) Regulation of mitochondrial processes by protein S-nitrosylation. Biochim Biophys Acta 1820(6):712–721
51. Doulias PT et al (2013) Nitric oxide regulates mitochondrial fatty acid metabolism through reversible protein S-nitrosylation. Sci Signal 6(256):rs1
52. Brown GC (2001) Regulation of mitochondrial respiration by nitric oxide inhibition of cytochrome c oxidase. Biochim Biophys Acta 1504(1):46–57
53. Sarti P et al (2003) Nitric oxide and mitochondrial complex IV. IUBMB Life 55(10–11):605–611
54. Nguyen TT et al (2011) Cysteine 203 of cyclophilin D is critical for cyclophilin D activation of the mitochondrial permeability transition pore. J Biol Chem 286(46):40184–40192
55. Murray CI et al (2011) Site-mapping of in vitro S-nitrosation in cardiac mitochondria: implications for cardioprotection. Mol Cell Proteomics 10(3):4721
56. Matsumoto A et al (2003) Screening for nitric oxide-dependent protein–protein interactions. Science 301(5633):657–661
57. Prime TA et al (2009) A mitochondria-targeted S-nitrosothiol modulates respiration, nitrosates thiols, and protects against ischemia–reperfusion injury. Proc Natl Acad Sci USA 106(26):10764–10769
58. Lima B et al (2009) Endogenous S-nitrosothiols protect against myocardial injury. Proc Natl Acad Sci USA 106(15):6297–6302
59. Burwell LS et al (2006) Direct evidence for S-nitrosation of mitochondrial complex I. Biochem J 394(Pt 3):627–634
60. Chouchani ET et al (2013) Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I. Nat Med 19(6):753–759
61. Hart GW et al (2011) Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. Annu Rev Biochem 80:825–858
62. Wang Z, Gucek M, Hart GW (2008) Cross-talk between GlcNAcylation and phosphorylation: site-specific phosphorylation dynamics in response to globally elevated O-GlcNAc. Proc Natl Acad Sci USA 105(37):13793–13798
63. Copeland RJ, Bullen JW, Hart GW (2008) Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity. Am J Physiol Endocrinol Metab 295(1):E17–E28
64. Ma J, Hart GW (2014) O-GlcNAc profiling: from proteins to proteomes. Clin Proteomics 11(1):8
65. Banerjee PS, Ma J, Hart GW (2015) Diabetes-associated dysregulation of O-GlcNAcylation in rat cardiac mitochondria. Proc Natl Acad Sci USA 112(19):6050–6055
66. Hanover JA et al (2003) Mitochondrial and nucleocytoplasmic isoforms of O-linked GlcNAc transferase encoded by a single mammalian gene. Arch Biochem Biophys 409(2):287–297
67. Love DC et al (2003) Mitochondrial and nucleocytoplasmic targeting of O-linked GlcNAc transferase. J Cell Sci 116(Pt 4):647–654
68. Gawlowski T et al (2012) Modulation of dynamin-related protein 1 (DRP1) function by increased O-linked-beta-N-acetylglucosamine modification (O-GlcNAc) in cardiac myocytes. J Biol Chem 287(35):30024–30034
69. Cao W et al (2013) Discovery and confirmation of O-GlcNAcylated proteins in rat liver mitochondria by combination of mass spectrometry and immunological methods. PLoS One 8(10):e76399
70. Ngoh GA et al (2008) Non-canonical glycosyltransferase modulates post-hypoxic cardiac myocyte death and mitochondrial permeability transition. J Mol Cell Cardiol 45(2):313–325
71. Hu Y et al (2009) Increased enzymatic O-GlcNAcylation of mitochondrial proteins impairs mitochondrial function in cardiac myocytes exposed to high glucose. J Biol Chem 284(1):547–555
72. Johnsen VL et al (2013) Enhanced cardiac protein glycosylation (O-GlcNAc) of selected mitochondrial proteins in rats artificially selected for low running capacity. Physiol Genomics 45(1):17–25
73. Tan EP et al (2014) Altering O-linked beta-N-acetylglucosamine cycling disrupts mitochondrial function. J Biol Chem 289(21):14719–14730
74. Shin SH, Love DC, Hanover JA (2011) Elevated O-GlcNAc-dependent signaling through inducible mOGT expression selectively triggers apoptosis. Amino Acids 40(3):885–893
75. Fricovsky ES et al (2012) Excess protein O-GlcNAcylation and the progression of diabetic cardiomyopathy. Am J Physiol Regul Integr Comp Physiol 303(7):R689–R699
76. Bennett CE et al (2013) Exercise training mitigates aberrant cardiac protein O-GlcNAcylation in streptozotocin-induced diabetic mice. Life Sci 92(11):657–663
77. Schwer B et al (2002) The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase. J Cell Biol 158(4):647–657
78. Michishita E et al (2005) Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Cell 16(10):4623–4635
79. Anderson KA, Hirschey MD (2012) Mitochondrial protein acetylation regulates metabolism. Essays Biochem 52:23–35
80. Scott I et al (2012) Identification of a molecular component of the mitochondrial acetyltransferase programme: a novel role for GCN5L1. Biochem J 443(3):655–661
81. Wagner GR, Payne RM (2013) Widespread and enzyme-independent Nepsilon-acetylation and Nepsilon-succinylation of proteins in the chemical conditions of the mitochondrial matrix. J Biol Chem 288(40):29036–29045
82. Pougovkina O et al (2014) Mitochondrial protein acetylation is driven by acetyl-CoA from fatty acid oxidation. Hum Mol Genet 23(13):3513–3522
83. Haigis MC et al (2006) SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell 126(5):941–954
84. Ahuja N et al (2007) Regulation of insulin secretion by SIRT4, a mitochondrial ADP-ribosyltransferase. J Biol Chem 282(46):33583–33592
85. Bharathi SS et al (2013) Sirtuin 3 (SIRT3) protein regulates long-chain acyl-CoA dehydrogenase by deacetylating conserved lysines near the active site. J Biol Chem 288(47):33837–33847
86. Hirschey MD et al (2010) SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 464(7285):121–125
87. Ozden O et al (2014) SIRT3 deacetylates and increases pyruvate dehydrogenase activity in cancer cells. Free Radic Biol Med 76:163–172
88. Schwer B et al (2006) Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2. Proc Natl Acad Sci USA 103(27):10224–10229
89. Someya S et al (2010) Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 143(5):802–812
90. Cimen H et al (2010) Regulation of succinate dehydrogenase activity by SIRT3 in mammalian mitochondria. Biochemistry 49(2):304–311
91. Finley LWS et al (2011) Succinate dehydrogenase is a direct target of sirtuin 3 deacetylase activity. PLoS One 6(8):e23295
92. Ahn B-H et al (2008) A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc Natl Acad Sci 105(38):14447–14452
93. Shinmura K et al (2011) Caloric restriction primes mitochondria for ischemic stress by deacetylating specific mitochondrial proteins of the electron transport chain. Circ Res 109(4):396–406
94. Rardin MJ et al (2013) Label-free quantitative proteomics of the lysine acetylome in mitochondria identifies substrates of SIRT3 in metabolic pathways. Proc Natl Acad Sci USA 110(16):6601–6606
95. Hafner AV et al (2010) Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy. Aging (Albany NY) 2(12):914–923
96. Fernandes J et al (2015) Lysine acetylation activates mitochondrial aconitase in the heart. Biochemistry 54(25):4008–4018
97. Vassilopoulos A et al (2014) SIRT3 deacetylates ATP synthase F1 complex proteins in response to nutrient- and exercise-induced stress. Antioxid Redox Signal 21:551–564
98. Bao J et al (2010) SIRT3 is regulated by nutrient excess and modulates hepatic susceptibility to lipotoxicity. Free Radic Biol Med 49(7):1230–1237
99. Ahn BH, Kim HS, Song S, Lee IH, Liu J, Vassilopoulos A, Deng CX, Finkel T (2008) A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. PNAS 105:14447–14452
100. Hallows WC, Lee S, Denu JM (2006) Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases. Proc Natl Acad Sci 103(27):10230–10235
101. Shimazu T et al (2010) SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production. Cell Metab 12(6):654–661
102. Laurent G et al (2013) SIRT4 coordinates the balance between lipid synthesis and catabolism by repressing malonyl CoA decarboxylase. Mol Cell 50(5):686–698
103. Shulga N, Wilson-Smith R, Pastorino JG (2010) Sirtuin-3 deacetylation of cyclophilin D induces dissociation of hexokinase II from the mitochondria. J Cell Sci 123(Pt 6):894–902
104. Jing E et al (2013) Sirt3 regulates metabolic flexibility of skeletal muscle through reversible enzymatic deacetylation. Diabetes 62(10):3404–3417
105. Chen Y et al (2011) Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS. EMBO Rep 12(6):534–541
106. Qiu X et al (2010) Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab 12(6):662–667
107. Tao R et al (2010) Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress. Mol Cell 40(6):893–904
108. Cheng Y et al (2013) Interaction of Sirt3 with OGG1 contributes to repair of mitochondrial DNA and protects from apoptotic cell death under oxidative stress. Cell Death Dis 4:e731
109. Winnik S et al (2015) Protective effects of sirtuins in cardiovascular diseases: from bench to bedside. Eur Heart J 36:3404–3412
110. Chen CJ et al (2013) SIRT3 protects cardiomyocytes from oxidative stress-mediated cell death by activating NF-kappaB. Biochem Biophys Res Commun 430(2):798–803
111. Cheung KG et al (2015) Sirtuin-3 (SIRT3) protein attenuates doxorubicin-induced oxidative stress and improves mitochondrial respiration in H9c2 cardiomyocytes. J Biol Chem 290(17):10981–10993
112. Tseng AH, Shieh SS, Wang DL (2013) SIRT3 deacetylates FOXO3 to protect mitochondria against oxidative damage. Free Radic Biol Med 63:222–234
113. Chen TS et al (2015) Mouse SIRT3 attenuates hypertrophy-related lipid accumulation in the heart through the deacetylation of LCAD. PLoS One 10(3):e0118909
114. Sundaresan NR, Gupta M, Kim G, Rajamohan SB, Isbatan A, Gupta MP (2009) Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J Clin Invest 119:2758–2771
115. Koentges C et al (2015) SIRT3 deficiency impairs mitochondrial and contractile function in the heart. Basic Res Cardiol 110(4):36
116. Porter GA et al (2014) SIRT3 deficiency exacerbates ischemia–reperfusion injury: implication for aged hearts. Am J Physiol Heart Circ Physiol 306(12):H1602–H1609
117. Park J et al (2013) SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways. Mol Cell 50(6):919–930
118. Rardin MJ et al (2013) SIRT5 regulates the mitochondrial lysine succinylome and metabolic networks. Cell Metab 18(6):920–933
119. Nishida Y et al (2015) SIRT5 regulates both cytosolic and mitochondrial protein malonylation with glycolysis as a major target. Mol Cell 59(2):321–332
120. Lin ZF et al (2013) SIRT5 desuccinylates and activates SOD1 to eliminate ROS. Biochem Biophys Res Commun 441(1):191–195
121. Tan M et al (2014) Lysine glutarylation is a protein posttranslational modification regulated by SIRT5. Cell Metab 19(4):605–617
122. Hottiger MO et al (2010) Toward a unified nomenclature for mammalian ADP-ribosyltransferases. Trends Biochem Sci 35(4):208–219
123. Szanto M et al (2012) Poly(ADP-ribose) polymerase-2: emerging transcriptional roles of a DNA-repair protein. Cell Mol Life Sci 69(24):4079–4092
124. Krietsch J et al (2013) Reprogramming cellular events by poly(ADP-ribose)-binding proteins. Mol Aspects Med 34(6):1066–1087
125. Ame JC et al (1999) PARP-2, A novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase. J Biol Chem 274(25):17860–17868
126. Ame JC, Spenlehauer C, de Murcia G (2004) The PARP superfamily. BioEssays 26(8):882–893
127. Schreiber V et al (2006) Poly(ADP-ribose): novel functions for an old molecule. Nat Rev Mol Cell Biol 7(7):517–528
128. Cohen-Armon M (2007) PARP-1 activation in the ERK signaling pathway. Trends Pharmacol Sci 28(11):556–560
129. Bai P (2015) Biology of poly(ADP-ribose) polymerases: the factotums of cell maintenance. Mol Cell 58(6):947–958
130. Hassa PO et al (2005) Acetylation of poly(ADP-ribose) polymerase-1 by p300/CREB-binding protein regulates coactivation of NF-kappaB-dependent transcription. J Biol Chem 280(49):40450–40464
131. Burkle A, Virag L (2013) Poly(ADP-ribose): PARadigms and PARadoxes. Mol Aspects Med 34(6):1046–1065
132. Rouleau M et al (2010) PARP inhibition: PARP1 and beyond. Nat Rev Cancer 10(4):293–301
133. Messner S et al (2009) Sumoylation of poly(ADP-ribose) polymerase 1 inhibits its acetylation and restrains transcriptional coactivator function. FASEB J 23(11):3978–3989
134. Mashimo M, Kato J, Moss J (2014) Structure and function of the ARH family of ADP-ribosyl-acceptor hydrolases. DNA Repair (Amst) 23:88–94
135. Min W, Wang ZQ (2009) Poly (ADP-ribose) glycohydrolase (PARG) and its therapeutic potential. Front Biosci (Landmark Ed) 14:1619–1626
136. Brunyanszki A et al (2016) Mitochondrial poly(ADP-ribose) polymerase: the Wizard of Oz at work. Free Radic Biol Med. doi:10.1016/j.freeradbiomed.2016.02.024 (Epub ahead of print)
137. Bai P et al (2015) Poly(ADP-ribose) polymerases as modulators of mitochondrial activity. Trends Endocrinol Metab 26(2):75–83
138. Szczesny B et al (2014) Opposing roles of mitochondrial and nuclear PARP1 in the regulation of mitochondrial and nuclear DNA integrity: implications for the regulation of mitochondrial function. Nucleic Acids Res 42(21):13161–13173
139. Andrabi SA et al (2014) Poly(ADP-ribose) polymerase-dependent energy depletion occurs through inhibition of glycolysis. Proc Natl Acad Sci USA 111(28):10209–10214
140. Niere M et al (2008) Functional localization of two poly(ADP-ribose)-degrading enzymes to the mitochondrial matrix. Mol Cell Biol 28(2):814–824
141. Cipriani G et al (2005) Nuclear poly(ADP-ribose) polymerase-1 rapidly triggers mitochondrial dysfunction. J Biol Chem 280(17):17227–17234
142. Sims JL, Berger SJ, Berger NA (1981) Effects of nicotinamide on NAD and poly(ADP-ribose) metabolism in DNA-damaged human lymphocytes. J Supramol Struct Cell Biochem 16(3):281–288
143. Haenni SS et al (2008) Identification of lysines 36 and 37 of PARP-2 as targets for acetylation and auto-ADP-ribosylation. Int J Biochem Cell Biol 40(10):2274–2283
144. Canto C, Sauve AA, Bai P (2013) Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes. Mol Aspects Med 34(6):1168–1201
145. + depletion and reduced Sir2alpha deacetylase activity. J Biol Chem 280(52):43121–43130
146. Bai P et al (2011) PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab 13(4):461–468
147. Gao J et al (2016) Deacetylation of MnSOD by PARP-regulated SIRT3 protects retinal capillary endothelial cells from hyperglycemia-induced damage. Biochem Biophys Res Commun 472(3):425–431